Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gasperini

Showing results (651-660 of 981) with videos related to

Pageof 99
Sort By:
The Journal of Vascular Access|July 6, 2023
Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experienceSilvio Ligia, Salvatore Giacomo Morano, Francesca Kaiser, et al.
Plos Neglected Tropical Diseases|October 13, 2021
Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypesFrancesco Citiulo, Francesca Necchi, Francesca Mancini, et al.
Journal of Neuroimmunology|June 16, 2000
Evidence for a role of gammadelta T cells in demyelinating diseases as determined by activation states and responses to lipid antigensG Borsellino, O Koul, R Placido, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 10, 2019
Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patientsAntonella Romaniello, Speranza Rubattu, Antonietta Gigante, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
European Journal of Physical and Rehabilitation Medicine|December 2, 2020
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticityAndrea Santamato, Salvatore Facciorusso, Stefania Spina, et al.
Annals of Neurology|March 20, 1998
Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosisP D Molyneux, M Filippi, F Barkhof, et al.
Plos One|January 30, 2026
Genetic diversity of alpha and betacoronaviruses in cave and temple-roosting bats in Vientiane Province, Lao PDRIllich Manfred Mombo, Novy Charel Bobouaka Bonguili, Nicola Gasperini, et al.
Journal of Neurology|April 17, 2002
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosisCarlo Pozzilli, Giovanni Antonini, Francesca Bagnato, et al.
Pageof 99

Showing results (651-660 of 981) with videos related to

Sort By:
Pageof 99
The Journal of Vascular Access|July 6, 2023
Peripherally inserted central venous catheter for pediatric acute leukemia: A retrospective 11-year single-center experienceSilvio Ligia, Salvatore Giacomo Morano, Francesca Kaiser, et al.
Plos Neglected Tropical Diseases|October 13, 2021
Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypesFrancesco Citiulo, Francesca Necchi, Francesca Mancini, et al.
Journal of Neuroimmunology|June 16, 2000
Evidence for a role of gammadelta T cells in demyelinating diseases as determined by activation states and responses to lipid antigensG Borsellino, O Koul, R Placido, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 10, 2019
Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patientsAntonella Romaniello, Speranza Rubattu, Antonietta Gigante, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Immunology Letters|January 14, 2014
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytesCristina Camperio, Michela Muscolini, Elisabetta Volpe, et al.
European Journal of Physical and Rehabilitation Medicine|December 2, 2020
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticityAndrea Santamato, Salvatore Facciorusso, Stefania Spina, et al.
Annals of Neurology|March 20, 1998
Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosisP D Molyneux, M Filippi, F Barkhof, et al.
Plos One|January 30, 2026
Genetic diversity of alpha and betacoronaviruses in cave and temple-roosting bats in Vientiane Province, Lao PDRIllich Manfred Mombo, Novy Charel Bobouaka Bonguili, Nicola Gasperini, et al.
Journal of Neurology|April 17, 2002
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosisCarlo Pozzilli, Giovanni Antonini, Francesca Bagnato, et al.
Pageof 99